DAS and Y27632 down-regulated the mRNA and protein expression of CK8-RhoA/ROCK1 pathway and up-regulated TJs expression in intestines of infected mice. by Wen Wen Zheng (17721404)

Subjects:

qPCR analysis of CK8 knockdown affecting Clauding-1 mRNA expression. by Wen Wen Zheng (17721404)

Subjects:

Molecular-docking simulation of the TsSPc–CK8 complex in Caco-2 cells. by Wen Wen Zheng (17721404)

Subjects:

CK8 knockdown and ROCK1 inhibitor abolished rTsSPc-reduced TJs expression in Caco-2 monolayers by IFA. by Wen Wen Zheng (17721404)

Subjects:

PAS staining of intestinal sections from <i>T. spiralis</i>-infected mice pretreated with DAS and Y27632. by Wen Wen Zheng (17721404)

Subjects:

qPCR and Western blotting of CK8 knockdown blocking the rTsSPc-activated pathway and -reduced TJs expression. by Wen Wen Zheng (17721404)

Subjects:

IFA, GST pull-down and Co-IP assay of specific binding between rTsSPc and CK8. by Wen Wen Zheng (17721404)

Subjects:

Transcription and expression levels of CK8 in Caco-2 cells after CK8 gene was knocked down. by Wen Wen Zheng (17721404)

Subjects:

qPCR and Western blotting of activation of CK8 receptor and RhoA/ROCK1 pathway proteins in Caco-2 cells treated with rTsSPc and IIL ES antigens. by Wen Wen Zheng (17721404)

Subjects:

CK8 knockdown and ROCK1 inhibitor suppressed rTsSPc-induced disruption of the Caco-2 monolayer and blocked rTsSPc-promoted IIL invasion. by Wen Wen Zheng (17721404)

Subjects:

HE staining showed that DAS and Y27632 alleviated intestinal inflammation in <i>T. spiralis</i>-infected mice. by Wen Wen Zheng (17721404)

Subjects:

The ROCK1 pathway inhibitor Y27632 prevented rTsSPc from activating the ROCK1 pathway and reducing TJs expression. by Wen Wen Zheng (17721404)

Subjects:

qPCR (A-D) and ELISA (E-H) detection of inflammatory cytokines in intestine of <i>T. spiralis</i>-infected mice. by Wen Wen Zheng (17721404)

Subjects:

Comparison of the predictive performance of GSRS, tumor mutational burden (TMB), and microsatellite instability (MSI) in forecasting immunotherapeutic response, as assessed by the... by Yu Zhang (12946)

Subjects:

EAPC in incidence and mortality of LC for age group. by Ze-Xing Zhang (18074512)

Subjects:

Cases and deaths of LC from the Chinese Annual Cancer Registry, 2004–2018. by Ze-Xing Zhang (18074512)

Subjects:

Changes in LC cases and deaths in male and female from 2004 to 2018, decomposed by three population-level determinants: population aging, population growth and epidemiological chan... by Ze-Xing Zhang (18074512)

Subjects:

Projected ASIR and ASMR of LC in China over the next 15 years based on the Bayesian APC model. by Ze-Xing Zhang (18074512)

Subjects:

The incidence and mortality data of LC by age group from the Chinese Annual Cancer Registry, 2004–2018. by Ze-Xing Zhang (18074512)

Subjects:

Contribution of changes in population aging, population growth, and age-specific incidence rate to changes in incident cases of LC from 2004 to 2018 in China. by Ze-Xing Zhang (18074512)

Subjects: